檢索結果 - Chris Verslype

Refine Results
  1. 1
    Hepatocellular carcinoma: ESMO–ESDO Clinical Practice Guidelines for diagnosis, treatment and follow-up

    Hepatocellular carcinoma: ESMO–ESDO Clinical Practice Guidelines for diagnosis, treatment and follow-up 由 Chris Verslype, Olivier Rosmorduc, P. Rougier

    出版 2012
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  2. 2
    Tumor initiation and progression in hepatocellular carcinoma: risk factors, classification, and therapeutic targets

    Tumor initiation and progression in hepatocellular carcinoma: risk factors, classification, and therapeutic targets 由 Tamara Severi, Hannah van Malenstein, Chris Verslype, Jos van Pelt

    出版 2010
    獲取全文 獲取全文
    Revisão
    加到收藏夾
    Saved in:
  3. 3
    Review article: non‐biological liver support in liver failure

    Review article: non‐biological liver support in liver failure 由 Wim Laleman, Alexander Wilmer, Pieter Evenepoel, Chris Verslype, Johan Fevery, Frederik Nevens

    出版 2006
    獲取全文 獲取全文
    Revisão
    加到收藏夾
    Saved in:
  4. 4
    Sorafenib: from literature to clinical practice

    Sorafenib: from literature to clinical practice 由 V. Di Marco, F. De Vita, John Koskinas, David Semela, Pierluigi Toniutto, Chris Verslype

    出版 2013
    獲取全文 獲取全文
    Revisão
    加到收藏夾
    Saved in:
  5. 5
    Applications of single-cell multi-omics in liver cancer

    Applications of single-cell multi-omics in liver cancer 由 Frederik Peeters, Sarah Cappuyns, Marta Piqué‐Gili, Gino Phillips, Chris Verslype, Diether Lambrechts, Jeroen Dekervel

    出版 2024
    獲取全文 獲取全文
    Revisão
    加到收藏夾
    Saved in:
  6. 6
    Acriflavine Inhibits Acquired Drug Resistance by Blocking the Epithelial-to-Mesenchymal Transition and the Unfolded Protein Response

    Acriflavine Inhibits Acquired Drug Resistance by Blocking the Epithelial-to-Mesenchymal Transition and the Unfolded Protein Response 由 Jeroen Dekervel, Ashenafi Bulle, Petra Windmolders, Diether Lambrechts, Eric Van Cutsem, Chris Verslype, Jos van Pelt

    出版 2016
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  7. 7
    Review article: blood platelet number and function in chronic liver disease and cirrhosis

    Review article: blood platelet number and function in chronic liver disease and cirrhosis 由 Peter Witters, Kathleen Freson, Chris Verslype, K. Peerlinck, Marc Hoylaerts, Frederik Nevens, Chris Van Geet, David Cassiman

    出版 2008
    獲取全文 獲取全文
    Revisão
    加到收藏夾
    Saved in:
  8. 8
    <sup>18</sup>F-Labeled Somatostatin Analogs as PET Tracers for the Somatostatin Receptor: Ready for Clinical Use

    <sup>18</sup>F-Labeled Somatostatin Analogs as PET Tracers for the Somatostatin Receptor: Ready for Clinical Use 由 Hannes Leupe, Stephen Ahenkorah, Jeroen Dekervel, Marcus Unterrainer, Eric Van Cutsem, Chris Verslype, Frederik Cleeren, Christophe M. Deroose

    出版 2023
    獲取全文 獲取全文
    Revisão
    加到收藏夾
    Saved in:
  9. 9
    Effect of the molecular adsorbent recirculating system and Prometheus devices on systemic haemodynamics and vasoactive agents in patients with acute-on-chronic alcoholic liver failure.

    Effect of the molecular adsorbent recirculating system and Prometheus devices on systemic haemodynamics and vasoactive agents in patients with acute-on-chronic alcoholic liver fail... 由 Wim Laleman, Alexander Wilmer, Pieter Evenepoel, Ingrid Vander Elst, Marcel Zeegers, Zahur Zaman, Chris Verslype, Johan Fevery, Frederik Nevens

    出版 2006
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  10. 10
    Acute-on-chronic liver failure: current concepts on definition, pathogenesis, clinical manifestations and potential therapeutic interventions

    Acute-on-chronic liver failure: current concepts on definition, pathogenesis, clinical manifestations and potential therapeutic interventions 由 Wim Laleman, Len Verbeke, Philippe Meersseman, Joost Wauters, Jos van Pelt, David Cassiman, Alexander Wilmer, Chris Verslype, Frederik Nevens

    出版 2011
    獲取全文 獲取全文
    Revisão
    加到收藏夾
    Saved in:
  11. 11
    A Randomized Phase II Study of Drug-Eluting Beads versus Transarterial Chemoembolization for Unresectable Hepatocellular Carcinoma

    A Randomized Phase II Study of Drug-Eluting Beads versus Transarterial Chemoembolization for Unresectable Hepatocellular Carcinoma 由 Hannah van Malenstein, Geert Maleux, Vincent Vandecaveye, Sam Heye, Wim Laleman, Jos van Pelt, Johan Vaninbroukx, Frederik Nevens, Chris Verslype

    出版 2011
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  12. 12
    Oxidative Stress and Oval Cell Accumulation in Mice and Humans with Alcoholic and Nonalcoholic Fatty Liver Disease

    Oxidative Stress and Oval Cell Accumulation in Mice and Humans with Alcoholic and Nonalcoholic Fatty Liver Disease 由 Tania Roskams, Shi Qi Yang, Aymen Koteish, Anne Durnez, R Devos, Xiawen Huang, Ruth Achten, Chris Verslype, Anna Mae Diehl

    出版 2003
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  13. 13
    Liver Fibrosis Associated with Iron Accumulation Due to Long-Term Heme-Arginate Treatment in Acute Intermittent Porphyria: A Case Series

    Liver Fibrosis Associated with Iron Accumulation Due to Long-Term Heme-Arginate Treatment in Acute Intermittent Porphyria: A Case Series 由 Barbara Willandt, Janneke G. Langendonk, Katharina Biermann, Wouter Meersseman, F D’Heygere, C. George, Chris Verslype, Diethard Monbaliu, David Cassiman

    出版 2015
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  14. 14
    Peptide Receptor Radionuclide Therapy Targeting the Somatostatin Receptor: Basic Principles, Clinical Applications and Optimization Strategies

    Peptide Receptor Radionuclide Therapy Targeting the Somatostatin Receptor: Basic Principles, Clinical Applications and Optimization Strategies 由 Niloefar Ahmadi Bidakhvidi, Karolien Goffin, Jeroen Dekervel, Kristof Baete, Kristiaan Nackaerts, Paul M. Clément, Eric Van Cutsem, Chris Verslype, Christophe M. Deroose

    出版 2021
    獲取全文 獲取全文
    Revisão
    加到收藏夾
    Saved in:
  15. 15
    Non-invasive liver elastography (Fibroscan) for detection of cystic fibrosis-associated liver disease

    Non-invasive liver elastography (Fibroscan) for detection of cystic fibrosis-associated liver disease 由 Peter Witters, K. De Boeck, Lieven Dupont, Marijke Proesmans, F. Vermeulen, R Servaes, Chris Verslype, Wim Laleman, Frederik Nevens, Ilse Hoffman, David Cassiman

    出版 2009
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  16. 16
    Cetuximab Monotherapy and Cetuximab plus Irinotecan in Irinotecan-Refractory Metastatic Colorectal Cancer

    Cetuximab Monotherapy and Cetuximab plus Irinotecan in Irinotecan-Refractory Metastatic Colorectal Cancer 由 David Cunningham, Yves Humblet, Salvatore Siena, David Khayat, Harry Bleiberg, Armando Santoro, D. Bets, M. Mueser, A. Harstrick, Chris Verslype, Ian Chau, Eric Van Cutsem

    出版 2004
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  17. 17
    A Seven-Gene Set Associated with Chronic Hypoxia of Prognostic Importance in Hepatocellular Carcinoma

    A Seven-Gene Set Associated with Chronic Hypoxia of Prognostic Importance in Hepatocellular Carcinoma 由 Hannah van Malenstein, Olivier Gevaert, Louis Libbrecht, Anneleen Daemen, Joke Allemeersch, Frederik Nevens, Eric Van Cutsem, David Cassiman, Bart De Moor, Chris Verslype, Jos van Pelt

    出版 2010
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  18. 18
    YAP and TAZ Heterogeneity in Primary Liver Cancer: An Analysis of Its Prognostic and Diagnostic Role

    YAP and TAZ Heterogeneity in Primary Liver Cancer: An Analysis of Its Prognostic and Diagnostic Role 由 Matthias Van Haele, Iván M. Moya, Ruçhan Karaman, Guy Rens, J. Snoeck, Olivier Govaere, Frederik Nevens, Chris Verslype, Baki Topal, Diethard Monbaliu, Georg Halder, Tania Roskams

    出版 2019
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  19. 19
    Circulating DNA as prognostic biomarker in patients with advanced hepatocellular carcinoma: a translational exploratory study from the SORAMIC trial

    Circulating DNA as prognostic biomarker in patients with advanced hepatocellular carcinoma: a translational exploratory study from the SORAMIC trial 由 Marianna Alunni‐Fabbroni, Kerstin Rönsch, Thomas S. Huber, Clemens C. Cyran, Max Seidensticker, Julia Mayerle, Maciej Pech, Bristi Basu, Chris Verslype, Julia Benckert, Peter Malfertheiner, Jens Ricke

    出版 2019
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  20. 20
    Phase III Trial of Bevacizumab in Combination With Gemcitabine and Erlotinib in Patients With Metastatic Pancreatic Cancer

    Phase III Trial of Bevacizumab in Combination With Gemcitabine and Erlotinib in Patients With Metastatic Pancreatic Cancer 由 Eric Van Cutsem, Walter L. Vervenne, Jaafar Bennouna, Yves Humblet, Sharlene Gill, Jean‐Luc Van Laethem, Chris Verslype, Werner Scheithauer, Aijing Shang, Jan Cosaert, Malcolm J. Moore

    出版 2009
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:

檢索工具: